Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

2.

Comparison of circumferential resection margin clearance criteria with survival after surgery for cancer of esophagus.

Rao VS, Yeung MM, Cooke J, Salim E, Jain PK.

J Surg Oncol. 2012 Jun 15;105(8):745-9. doi: 10.1002/jso.23006. Epub 2011 Dec 12.

PMID:
22161989
3.

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators.

Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x.

PMID:
21679231
4.

Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).

Goodman SG, Langer A, Bastien NR, McPherson R, Francis GA, Genest JJ Jr, Leiter LA; DYSIS Canadian Investigators.

Can J Cardiol. 2010 Nov;26(9):e330-5.

5.

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH; OLYMPUS trial group.

Ann Neurol. 2009 Oct;66(4):460-71. doi: 10.1002/ana.21867.

PMID:
19847908
6.

Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial.

Metz LM, Li D, Traboulsee A, Myles ML, Duquette P, Godin J, Constantin M, Yong VW; GA/minocycline study investigators.

Mult Scler. 2009 Oct;15(10):1183-94. doi: 10.1177/1352458509106779. Epub 2009 Sep 23.

PMID:
19776092
7.

Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist.

Stadnyk AW, Yeung MM, Yan SR.

Dig Dis Sci. 2003 Sep;48(9):1737-44.

PMID:
14560993
8.

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.

Melgar S, Yeung MM, Bas A, Forsberg G, Suhr O, Oberg A, Hammarstrom S, Danielsson A, Hammarstrom ML.

Clin Exp Immunol. 2003 Oct;134(1):127-37.

9.

Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression.

Yeung MM, Melgar S, Baranov V, Oberg A, Danielsson A, Hammarström S, Hammarström ML.

Gut. 2000 Aug;47(2):215-27.

10.

Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.

Lundqvist C, Melgar S, Yeung MM, Hammarström S, Hammarström ML.

J Immunol. 1996 Sep 1;157(5):1926-34.

PMID:
8757311
11.

Cell- and region-specific expression of biliary glycoprotein and its messenger RNA in normal human colonic mucosa.

Frängsmyr L, Baranov V, Prall F, Yeung MM, Wagener C, Hammarström S.

Cancer Res. 1995 Jul 15;55(14):2963-7.

12.

Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy.

Mincheva-Nilsson L, Baranov V, Yeung MM, Hammarstrom S, Hammarstrom ML.

Adv Exp Med Biol. 1995;371A:367-71. No abstract available.

PMID:
8525945
14.

Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy.

Mincheva-Nilsson L, Baranov V, Yeung MM, Hammarström S, Hammarström ML.

J Immunol. 1994 Feb 15;152(4):2020-32.

PMID:
7509833
Items per page

Supplemental Content

Loading ...
Write to the Help Desk